1 option
Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?: Hearing of the Committee on Health, Education, Labor, and Pensions, U.S. Senate, One Hundred Eighteenth Congress, Second Session [2024]
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.